Document is current
Any future updates will be listed below
-
Authors
Kuang, Xiao https://orcid.org/0000-0001-6596-1417
Rong, Qiangzhou
Belal, Saud https://orcid.org/0009-0000-3335-7725
Wang, Nanchao https://orcid.org/0000-0002-5037-4145
Vu, Tri
Herrera-Ruiz, Abigail
Zhang, Zebang
Zhang, Yu Shrike https://orcid.org/0000-0002-0045-0808
Yao, Junjie https://orcid.org/0000-0002-2381-706X
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (R21EB025270, RF1NS115581)
- License Information
-
More Information
Article History
Received: 8 January 2025
Accepted: 30 July 2025
First Online: 15 October 2025
Competing interests
: Y.S.Z. consulted for Allevi by 3D Systems; cofounded, consults for and holds options in Linton Lifesciences; and sits on the scientific advisory board and holds options in Xellar Biosystems. The relevant interests are managed by the Brigham and Women’s Hospital. T.V. and J.Y. have financial interests with Lumius Imaging, Inc., which did not support this work. The other authors declare no competing interests.
